NSE · CONCORDBIO
Concord Biotech Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#454
of 5,072 stocks
▼ 101W
Peak #444 · 21 Sep 2026
Operating in Healthcare, Concord Biotech Limited carries a steep earnings multiple that prices in strong future growth, is seeing revenue contract sharply, and earns a healthy return on equity.
Market Cap
15,206.98 Cr
P/E Ratio
56.20
P/B Ratio
7.23
ROE
12.86%
ROCE
16.72%
Dividend Yield
0.54%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 257.49 Cr | 326.08 Cr | 277.77 Cr | 247.06 Cr |
| Net Profit | 57.70 Cr | 88.47 Cr | 63.64 Cr | 63.06 Cr |
| EPS | 5.52 | 8.46 | 6.08 | 6.03 |
| Operating Profit | 77.10 Cr | 114.34 Cr | 90.21 Cr | 83.45 Cr |
Shareholding pattern
Promoter
44.08%
Public
55.92%
PUBLIC BREAKDOWN
FII
7.52%
DII
9.36%
MF (within DII)
4.40%
Individuals
9.23%
Mutual fund holdings
₹897.62
Cr total
52
Schemes
21
Fund Houses
₹897.62 Cr
Total Exposure
DSP Mutual Fund₹485.32 Cr (54.1%)
SBI Mutual Fund₹159.68 Cr (17.8%)
Edelweiss Mutual Fund₹82.30 Cr (9.2%)
Helios Mutual Fund₹34.64 Cr (3.9%)
Quant Mutual Fund₹30.13 Cr (3.4%)
Others₹105.55 Cr (11.8%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 24 Jul 2026 | Dividend | Dividend - Rs 7.55 Per Share |
| 03 Sep 2025 | Dividend | Dividend - Rs 10.70 Per Share |
| 21 Jun 2024 | Dividend | Dividend - Rs 8.75 Per Share |
| 21 Jun 2024 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.